Neptune Wellness Solutions Logo
CA64079L1058
A2N6DW
NEPT

Neptune Wellness Solutions

Caricamento quotazioni...

Previsioni

Acquista
  1
Mantieni
  0
Vendi
  0

  • Neptune sets price for secondary offering at $27.50 per share

    Neptune set the price for a secondary offering of 9,841,395 Class A shares at $27.50 per share; the shares are being sold by selling shareholders and the company will not receive any proceeds. Neptune intends to repurchase and retire 984,140 shares from the underwriters at $26.40 per share; closing is expected on Friday and is subject to customary conditions and the successful completion of the offering. The underwriters have been granted a 30-day option to purchase up to 1,476,209 additional shares at the offering price. Morgan Stanley is lead left bookrunner; the S-1 was declared effective by the SEC on May 13, 2026. The stock is trading at $27.94, market capitalization is $3.95 billion, analysts expect a return to profitability, and InvestingPro currently views the stock as overvalued. » Altro su de.investing.com


  • Neptune announces secondary placement of 8.36 million shares by selling shareholders

    Certain selling shareholders of Neptune intend to publicly place 8,355,615 class A common shares; the syndicate banks have a 30-day option on up to 1,253,342 additional shares. Neptune will also repurchase 835,561 shares from the syndicate banks at the same price and cancel them, subject to customary closing conditions and a successful offering. Morgan Stanley is lead left bookrunner, J.P. Morgan and Goldman Sachs are active bookrunners; a Form S-1 registration statement has been filed with the SEC but is not yet effective. The announcement follows a 22% rise in the stock last week; Neptune is due to report results in two days, and analysts expect a return to profitability. » Altro su de.investing.com


  • Neptune targets IPO in New York after strong growth and high margin

    Flood insurer Neptune has filed for an IPO in New York and plans to list under the ticker NP. The company, founded in 2018, reported $119.3m in revenue and $34.6m in net income in 2024, implying roughly a 29% margin; H1 2025 also showed further strong growth. The offering is being led by Morgan Stanley, J.P. Morgan and BofA Securities, with BMO Capital Markets, Goldman Sachs and Evercore ISI as additional syndicate banks. » Altro su de.investing.com

Nel 2008, Neptune Wellness Solutions ha già distribuito +0,19 di dividendi. L'ultimo pagamento è avvenuto a agosto 2008.

Dati finanziari dell'azienda

Nell'ultimo anno, Neptune Wellness Solutions ha registrato ricavi pari a +48,40M e un utile netto di 75,17M
(EUR) 2023
YoY
Ricavi +48,40M 9,82%
Utile lordo 4,51M 58,63%
Utile netto 75,17M 11,21%
EBITDA 58,00M 19,61%

Dati fondamentali

Metrica Valore
Capitalizzazione di mercato
+735,53k
Numero di azioni
4,29M
Massimo/minimo a 52 settimane
+0,17 - +0,17
Dividendi No
Beta
2,19
Rapporto P/E
2,79
Rapporto PEG
0,02
Rapporto P/B
+4,94
Rapporto P/S
0,00

Profilo aziendale

Neptune Wellness Solutions Inc. ist als integriertes Gesundheits- und Wellnessunternehmen tätig. Es baut ein Portfolio von Lifestyle-Marken und Konsumgütern unter den Marken Biodroga Neutraceuticals, Forest Remedies, Ocean Remedies, Neptune Wellness, Mood Ring, PanHash, Sprout, Nosh und NurturMe auf. Das Unternehmen bietet schlüsselfertige Produktentwicklungs- und Lieferkettenlösungen für Geschäftskunden in verschiedenen Gesundheits- und Wellnessbereichen an, wie z. B. legales Cannabis und Hanf, Nahrungsergänzungsmittel und verpackte Konsumgüter mit weißem Etikett. Das Unternehmen befasst sich auch mit der Extraktion, Reinigung, Formulierung und Herstellung von Gesundheits- und Wellnessprodukten wie Omega-3- und Hanfprodukten in verschiedenen Darreichungsformen wie Softgels, Flüssigkeiten, Kapseln, Vape-Pens, Sprays, topischen Produkten, Beuteln, Tinkturen, Konzentraten, Esswaren und Getränken sowie Handdesinfektionsmitteln, berührungslosen Thermometern und Handschuhen. Darüber hinaus bietet das Unternehmen Maxsimil an, eine Technologie zur Verabreichung von Omega-3-Fettsäuren, bei der Enzyme verwendet werden, die das natürliche menschliche Verdauungssystem nachahmen, um Omega-3-Fettsäuren vorzuverdauen. Es hat eine Kooperationsvereinbarung mit International Flavors & Fragrances Inc. zur gemeinsamen Entwicklung von aus Hanf gewonnenen CBD-Produkten für den Masseneinzelhandel sowie den Gesundheits- und Wellnessmarkt. Das Unternehmen wurde 1998 gegründet und hat seinen Hauptsitz in Laval, Kanada.

Nome
Neptune Wellness Solutions
CEO
Lisa H. Gainsborg CPA
Sede centrale Laval, qc
Canada
Sito web
Settore
Materiali
Industria
Prodotti chimici
Quotazione in borsa
13/08/2007
Dipendenti 50

Simboli di borsa

Borsa Simbolo
NASDAQ
NEPT
🍪

Parqet  usa i cookie. Scopri di più